OWD
ZBH icon

Osborn Williams & Donohoe’s Zimmer Biomet ZBH Stock Holding History

Osborn Williams & Donohoe’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-180
Closed -$22K – 680
2019
Q1 		$22K Buy
+180
New +$20.5K ﹤0.01% 549

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osborn Williams & Donohoe's ZBH Position: Q2 2019 in Review

Osborn Williams & Donohoe sold out of Zimmer Biomet (ZBH) in Q2 2019, closing a stake of 180 shares — an estimated $22K sold.

Osborn Williams & Donohoe first reported a position in ZBH in Q1 2019 and held it in 1 quarter. The position peaked at $22K in Q1 2019. 883 funds tracked by Wall St. Rank hold ZBH as of Q2 2019.

  • Osborn Williams & Donohoe reported no remaining Zimmer Biomet position as of Q2 2019 after selling out during the quarter.
  • Osborn Williams & Donohoe sold 180 Zimmer Biomet shares in Q2 2019, an estimated $22K.
  • Osborn Williams & Donohoe first reported a position in Zimmer Biomet in Q1 2019 and held it in 1 quarter.
  • Osborn Williams & Donohoe's Zimmer Biomet position peaked at $22K in Q1 2019.
  • 883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2019.

Based on Osborn Williams & Donohoe's 13F filing for Q2 2019, filed 26 Jul 2019.